GSTA2 and hepatocellular carcinoma: Overexpression of GSTA2 in HCC cells enhanced the activation of the AKT pathway under ROS-stimulation, while suppression of GSTA2 inhibited the activation of the AKT pathway in HCC cells (Fig. 3d).